Altamira Therapeutics to Host Investor & Business Update Call on December 11th

[ad_1] Altamira Therapeutics Ltd HAMILTON, BERMUDA , Dec. 05, 2023 (GLOBE NEWSWIRE) — HAMILTON, BERMUDA–December 5, 2023–Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq: CYTO), a company dedicated to developing…

Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business

[ad_1] Altamira Therapeutics Ltd Initiates Strategic Repositioning to Focus on Company’s Core RNA Delivery Technology Altamira Therapeutics retains 49% in Altamira Medica AG, and secures 25% of future licensing revenue…